Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Conventional financing remains a hurdle for pharma innovation, say industry leaders
India has the potential to move up the pharmaceutical value chain from its existing dominant position as a major generics manufacturer globally to a big player in innovation, particularly drug discovery, if such efforts are supported by adequate…
Zealand Pharma announces positive Phase 1a topline results with Kv1.3 channel blocker ZP9830
Press release – No. 4 / 2026 Zealand Pharma announces positive Phase 1a topline results with Kv1.3 channel blocker ZP9830 Single doses of ZP9830 were well tolerated, with no serious or severe adverse events or dose-limiting safety findings…
Obesity Drug Boom Buoys Ireland's Pharma Production for Export
This article is for subscribers only. A nondescript industrial estate in Ireland's Midlands region is about to become a flashpoint in the race to dominate the weight-loss drug market. Danish pharmaceutical giant Novo Nordisk is planning to boost…
Essential Pharma strengthens rare disease portfolio with acquisition of Ventavis (iloprost trometamol) for adult primary pulmonary hypertension
Ventavis is an established inhaled prostacyclin analogue for the treatment of primary pulmonary hypertension Acquisition reinforces Essential Pharma's mission to serve the needs of rare disease populations and enhances reputation as a trusted…
Pharma Sector Shifting to AI-Led Innovation
Hyderabad:The pharmaceutical industry is shifting from linear drug development models to an integrated innovation architecture that combines advanced biology, artificial intelligence and digitally enabled manufacturing, according to a report. The…
Madrigal Pharma: What To Expect With Q4 Earnings Coming Thursday (NASDAQ:MDGL)
Madrigal Pharmaceuticals is reiterated as a Strong Buy ahead of Q4 earnings, with a 12-month price target of $665, implying 43% upside. Rezdiffra's rapid commercialization and first-mover advantage in the MASH market underpin robust sales growth…
Platform models gaining ground in pharma R&D: Report
Rising scientific complexity is pushing companies to redesign R&D (research and development) around platform-based models rather than one-off products, according to a study by EY-Parthenon India. The report – Pharma's New Architecture: Where…
Next round of growth in pharma, life sciences will be in high value products: CEOs
To further harness global opportunity in pharma and life sciences, Indian industry needs to move up on the value chain to become a capability leader with focus on high-value products, according to industry captains. The journey towards this end has…
Aquestive Therapeutics: A Forensic Analysis Of The Anaphylm CRL (NASDAQ:AQST)
Aquestive Therapeutics is rated Strong Buy with a $7 target, implying 92% upside, driven by regulatory clarity and mispricing. The FDA's Complete Response Letter for Anaphylm is viewed as a 12-month delay, not a fundamental risk, with a 99.2%…
BridgeBio Pharma (NASDAQ:BBIO) Price Target Raised to $100.00
BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) had its target price raised by research analysts at HC Wainwright from $90.00 to $100.00 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage currently has a 'buy'…
Cibc World Market Inc. Invests $1.23 Million in Ascendis Pharma A/S $ASND
Cibc World Market Inc. acquired a new stake in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) during the third quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 6,168 shares of the biotechnology…
Keen on making Hyderabad lab of the future: Sridhar Babu
IT and Industries Minister D.Sridhar Babu on Tuesday said Telangana government wants to transform Hyderabad into a global hub for innovation-led Life Sciences growth, a ‘laboratory of the future'. Speaking at BioAsia, which opened here on…
Trump tariffs: Irish exports to US soared in 2025
Mandel NGAN / AFP via Getty Images Economics and business editor, BBC News NI The value of Irish goods exports to the United States soared by 52% to almost €112bn (£97bn) in 2025, official figures suggest. The export performance was…
Decoding mutual fund sector allocation trends
Within equity-oriented mutual funds, Banks, IT-Software, Finance, Pharma and Automobiles remained the most preferred sectors. Banks continued as the largest allocation at nearly 22% of equity AUM, also recording the biggest absolute rise of 31% in…
GSK: Post-Pivot Buoyancy Set To Continue After Strong 2025 (Upgrade) (NYSE:GSK)
GSK plc is a pharma worthy of a Buy rating, based on past performance and future prospects. In 2025, the company grew revenues by 7% and core EPS by 12%. GSK seems to have successfully pivoted into a 'pure-play' Pharma having ditched its consumer…
Receive a Daily briefing on Pharma Industry News
Get Started